H1N1 Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2024

Request Brochure Request Discount

Report Code: ZMR-2976 | Report Format : | Status : Upcoming |

Abstract

H1N1 Vaccines Market: Overview

The H1N1 flu epidemic created a public health emergency in 2009. It also created an opportunity for vaccine manufacturers to exhibit that working with various initiatives, both private and government-held entities around the world, they could manufacture and distribute a vaccine for the virus strain which resulted in rapidly rising deaths worldwide.

H1N1 influenza virus vaccine is used to prevent infection caused by the H1N1 influenza virus.

H1N1 Vaccines Market: Market Dynamics

Some of the major anticipated drivers for this market include resurgence of H1N1 virus, emerging economies, irregular mutation of the virus which generates the need for continuous innovation of new vaccines, antigenic shifts of the virus leads to generation of new influenza virus types, innovation in vaccine manufacturing in order to obtain a universally acceptable vaccine for H1N1 virus, increased awareness on H1N1 influenza, Cost effective manufacturing of H1N1 vaccine, New funding opportunities by government, NGOs and donations, new research techniques and vaccine manufacturing technologies, new target population and improved profitability for the industry.

Unaffordable prices of the H1N1 vaccines by the lower and middle-class group, long period of time invested for discovering a new form of the vaccine, stringent regulatory rules, the absence of experienced medical professionals and high capital requirement are expected to restrain the growth of H1N1 vaccines market

Ample production to meet the population demand, developing vaccine much more effective than the current ones are few challenges forecasted in this market.

Segmentation based on the type of vaccine:

Based on vaccine type the market is categorized into intranasal, conjugate, attenuated vaccines, inactivated vaccine, intramuscular and toxoid.

Segmentation based on the disease type:

On the basis of disease type, the market is segmented by cervical cancer, influenza, mumps, measles, meningococcal, hepatitis, pneumococcal, rubella and other disease types.

Segmentation based on the brand type:

Depending on the type of brand devices, the market is segregated into agripal, nasovac, influvac, fiuarix, vaxigrip, influgen and other brands.

Segmentation based on regions:

North America and Europe dominate the global H1N1 vaccines market due to their improved research infrastructure and developing research techniques leading to the faster discovery of the disease prevention. The U.S. holds the largest market for H1N1 vaccines in North America, which is followed by Canada. Japan, China, and India are anticipated to be the fastest growing H1N1 vaccines market in Asia owing to the increasing awareness among people about preventable diseases, government launched programs to eradicate such infectious diseases and their causes, low wages to be paid to the workers, availability of a large talent pool and skilled personnel and less stringent environment and health safety regulations in these regions.

H1N1 Vaccines Market: Competitors

Abbott labs, CPL Biologicals Pvt. Ltd., bioCSL, GlaxoSmithKline Plc, MedImmune LLC, Novartis AG, Sanofi Pasteur AG, AstraZeneca, Baxter International, Mitsubishi Tanabe Pharma, Sinovac Biotech Ltd., Protein Sciences Corporation and Zydus Cadila are few of the key players in this market.

H1N1 Vaccines Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Peptide and Anticoagulant Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-3130 | Report Format:

Global Peptide and Anticoagulant Drugs Market: Overview Peptides anticoagulant drugs are likely to have a wide range of applications in treating several diseases for example osteoporosis, cancer, cardiovascular, diabetes, and coagulation disorders. Peptides are basically molecules that are univ...Read More

Crohn’s Disease Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3999.00 | Report Code: ZMR-3033 | Report Format:

Global Crohns Disease Market: Overview An inflammatory disease of bowel affecting any part of the Gastro-Intestinal Tract (GI Tract) is termed as Crohns disease. It is classified into a segment of chronic disease. Crohns disease is considered to impact nearly every part of an individuals life, a...Read More

Anti-Neoplastic Agents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-3024 | Report Format:

Global Anti-Neoplastic Agents Market: Overview Anti-neoplastic agents are primarily used as a first-line treatment for cancer therapy as well as in combination with radiation or surgical therapy. A lot of anti-neoplastic agents are accessible commercially for the therapy of various kinds of canc...Read More

Kidney Fibrosis Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-2989 | Report Format:

Global Kidney Fibrosis Treatment Market: Overview Fibrosis is the growth of extreme connective tissue owing to some injury or some disease. Disease in the kidney can cause kidney fibrosis. In this state, the kidneys fail to work properly which gradually leads to severe conditions. Kidney transpl...Read More

Oncology Based In-vivo CRO Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2982 | Report Format:

Global Oncology Based In-vivo CRO Market: Overview CRO basically stands for contract research organization which presents research services to a pharmaceutical, biotechnology, and medical devices key players on the basis of the contract. CRO offers services such as clinical research, biologic as...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.